Overview

Bupivacaine Epiphora Trial

Status:
Suspended

Trial end date:
2021-08-01

Target enrollment:
0

Participant gender:
All

Summary

The objective of this study is to investigate quantitative improvement in excessive tearing after administration of Bupivacaine, a local anesthetic, into the affected eyelids.

Phase:

Phase 2

Accepts Healthy Volunteers?

Accepts Healthy Volunteers

Details

Lead Sponsor:

McMaster University

Collaborator:

Icahn School of Medicine at Mount Sinai

Treatments:

Bupivacaine

Criteria

Inclusion Criteria:

Patients age 18 and above, patients with unilateral or bilateral excessive tearing.

Exclusion Criteria:

Pregnant females, vulnerable populations, patients with severe hepatic disease, or patients
using monoamine oxidase inhibitors or tricyclic antidepressants, which are contraindicated
with bupivacaine and norepinephrine combinations.